United States v. Dana Eller ( 2020 )

United States Court of Appeals
For the Eighth Circuit
___________________________
No. 19-1759
___________________________
United States of America
lllllllllllllllllllllPlaintiff - Appellee
v.
Dana Andrew Eller
lllllllllllllllllllllDefendant - Appellant
____________
Appeal from United States District Court
for the Southern District of Iowa - Des Moines
____________
Submitted: January 13, 2020
Filed: April 9, 2020
____________
Before SMITH, Chief Judge, LOKEN and GRUENDER, Circuit Judges.
____________
SMITH, Chief Judge.
Dana Eller pleaded guilty to (1) possession of methamphetamine and marijuana
with intent to distribute and (2) possession of a firearm in furtherance of a drug
trafficking crime. After he reviewed his draft presentence investigation report (PSR),
Eller moved to withdraw his plea. The district court1 denied that motion. We affirm.
I. Background
Postal employees informed law enforcement that they had intercepted a
package that smelled strongly of marijuana. The shipping label indicated that the
package was going to Eller’s house. Officers had other information that indicated
Eller was selling drugs out of that house. After conducting a controlled delivery of
the package, officers obtained and executed a search warrant. The officers discovered
drugs, paraphernalia, and weapons within Eller’s residence. They arrested Eller, who
agreed to plead guilty to possession with intent to distribute, see 21 U.S.C.
§ 841(a)(1), (b)(1)(A), and (b)(1)(D), and possession of a firearm in furtherance of
a drug trafficking crime. See 18 U.S.C. § 924(c)(1)(A)(i). He signed the plea
agreement on August 22, 2018.
The district court held Eller’s change-of-plea hearing two days later. During
that hearing, the district court asked Eller a series of questions to ensure that he (1)
was competent to plead guilty, (2) understood the charges against him, (3)
comprehended the factual basis for those charges, (4) understood the rights he would
waive by pleading guilty, and (5) recognized the effects of his plea. Eller’s responses
raised no suspicions as to his competence or his understanding of the charges and the
effects of his plea.
During one part of the exchange, Eller disclosed that he was taking one
medication for an abscessed tooth, and another for anxiety, depression, attention
deficit disorder, and attention deficit hyperactivity disorder. The depression
medication, Cymbalta, was prescribed by a doctor at the jail. Eller took it for the first
1
The Honorable Stephanie M. Rose, United States District Judge for the
Southern District of Iowa.
-2-
time the morning of his change-of-plea hearing. When asked if he was feeling any
side effects from the medication, Eller stated he was “[j]ust tired.” Plea Hr’g Tr. at 5,
United States v. Eller, No. 4:18-cr-00142-SMR-CFB-1 (S.D. Iowa Nov. 30, 2018),
ECF No. 47. Eller’s counsel also expressed that he had no reason to believe Eller was
incompetent to enter his plea. The court found that Eller was competent to enter a
plea.
About two weeks after the hearing, Eller complained that Cymbalta was
causing side effects. These included cold sweats, vomiting, migraines, dizziness,
sleepiness, and trouble thinking. He eventually switched medications.
In October, a draft PSR was filed. Eller objected to the draft for several factual
reasons, including a correction that his medication had changed from Cymbalta to
Prozac. He did not, however, assert that he was incompetent at the time of his change-
of-plea hearing.
On December 4, 2018, Eller’s counsel requested a continuance of Eller’s
sentencing. He expressed concerns about Eller’s competence “based on (a) [Eller’s]
responses to counsel’s questioning, (b) changes to [Eller’s] medication regiment, (c)
[Eller’s] statements regarding his mental health, and ([d]) counsel’s observations
regarding [Eller’s] ability to focus and understand.” Suppl. Info. Regarding
Competency Eval. at 1, United States v. Eller, No. 4:18-cr-00142-SMR-CFB-1 (S.D.
Iowa Dec. 4, 2018), ECF No. 54. Eller later filed a motion to withdraw his guilty plea.
He argued that his plea was not knowing and voluntary because the Cymbalta he took
on the day of his change-of-plea hearing made him tired and cloudy headed,
inhibiting his ability to understand.
The district court denied Eller’s motion. It noted that, during the plea colloquy,
Eller “timely, appropriately, and lucidly answered each question posed by the Court.”
Order Den. Def.’s Mot. to Withdraw Plea of Guilty at 2, United States v. Eller, No.
-3-
4:18-cr-00142-SMR-CFB-1 (S.D. Iowa Feb. 6, 2019), ECF No. 65. It also noted that
Eller provided no evidence to prove “that a single 30 mg time delayed dose of
Cymbalta has the capacity to render a defendant incompetent.” Id. Further, the court
discounted Eller’s subjective complaints because they were unsworn and self-serving.
Finally, the court found the timing of Eller’s motion suspicious; Eller did not move
to withdraw his plea or complain of his incompetence until after his draft PSR was
filed. That timing indicated “buyer’s remorse.” Id. at 4. Consequently, the district
court denied Eller’s motion. Eller appeals that decision.
II. Discussion
Eller argues that the district erred in denying his motion to withdraw his guilty
plea. “This court reviews the denial of a motion to withdraw a plea for an abuse of
discretion.” United States v. Cruz, 643 F.3d 639, 641 (8th Cir. 2011). “A defendant
may withdraw a plea of guilty . . . after the court accepts the plea . . . if . . . the
defendant can show a fair and just reason for requesting the withdrawal.” Fed. R.
Crim. P. 11(d)(2)(B). “The defendant bears the burden to establish fair and just
grounds for withdrawal.” Cruz, 643 F.3d at 642. “[A] defendant seeking to withdraw
a plea before sentencing is given a more liberal consideration than someone seeking
to withdraw a plea after sentencing . . . .” United States v. Prior, 107 F.3d 654, 657
(8th Cir. 1997). Still, “[e]ven if the defendant meets this burden, the court must
consider other factors before granting the motion.” Cruz, 643 F.3d at 642. These
include “whether the defendant asserts his innocence of the charge, the length of time
between the guilty plea and the motion to withdraw it, and whether the government
will be prejudiced if the court grants the motion.” United States v.
Ramirez-Hernandez, 449 F.3d 824, 826 (8th Cir. 2006) (internal quotation omitted).
Eller has not established fair and just grounds for withdrawal. In Prior, the
defendant alleged that a guilty plea was induced by drug-withdrawal symptoms. 107
F.3d at 657. An expert testified that the defendant was incompetent when he signed
the plea agreement but competent at his plea hearing. Id. The hearing transcript also
-4-
indicated that the defendant was competent; he stated that he understood his rights,
read the plea agreement multiple times, and conferred with his counsel. Id. at 658.
Further, the district court explained the defendant’s constitutional rights, and the
defendant admitted he voluntarily signed the plea agreement. Id. Additionally, the
defendant did not seek to withdraw his plea until approximately five months after his
hearing. Id. Under those circumstances, we concluded that the district court did not
abuse its discretion in denying the motion. Id.
In United States v. Taylor, the defendant claimed that he was under the
influence of drugs and depressed at his plea hearing. 515 F.3d 845, 851 (8th Cir.
2008). We held that he failed to establish a fair and just reason for withdrawing his
plea. Id. Specifically, the district court adequately inquired into the defendant’s
mental state and explained the consequences of his plea. Id. Additionally, the
defendant’s counsel stated that she believed the defendant was competent. Id. And the
defendant’s credibility was diminished because he (1) alleged that he lied under oath
and (2) waited until the PSR was released to withdraw his plea. Id.; see also United
States v. Yell, 18 F.3d 581, 582–83 (8th Cir. 1994) (finding a defendant failed to meet
his burden because he was fully informed, the court performed a colloquy into his
understanding, and his claim of stress was “without credible foundation”).
And in Cruz, the defendant argued, among other things, “that he was confused
during the plea hearing due to his cold medication.” 643 F.3d at 642. But at the plea
hearing, the defendant testified that the medicine did not affect his judgment. Id.
Further, at a later hearing, the defendant only testified that the medicine might have
affected his ability to understand. Id. We found that evidence fell short of satisfying
the defendant’s burden. Id.
Eller argues that he was suffering mental illness at the time of his plea hearing,
and that Cymbalta exacerbated his mental illness. This resulted, he claims, in an
unknowing and involuntary plea. The only evidence supporting Eller’s claim is
-5-
(1) Eller’s self-serving testimony that he was tired and fuzzy at the plea hearing and
(2) prison medical records, which indicated that Eller complained two weeks after his
hearing that the medicine caused side effects. Those side effects included cold sweats,
vomiting, migraines, dizziness, sleepiness, and trouble thinking.
That evidence is insufficient to establish a fair and just grounds for withdrawal.
First, the plea hearing transcript belies any contention that Eller did not knowingly
and voluntarily enter his plea. Eller swore under oath that he understood the plea
agreement and that he had no reason to doubt his competency. His counsel also
testified that he believed Eller was competent. Further, the district court explained the
consequences and rights Eller waived by pleading guilty. We have found that similar
transcripts overcome a defendant’s later subjective complaints. See Cruz, 643 F.3d
at 642; Prior, 107 F.3d at 657–58.
Second, the symptoms indicated in prison medical records are based on solely
Eller’s statements. Such unsupported statements provide an inadequate basis for
establishing the invalidity of his plea. See United States v. Dalman, 994 F.2d 537,
538–39 (8th Cir. 1993) (rejecting the defendant’s contention that his medication
unduly influenced his plea because those contentions were contrary to his conduct
and testimony at the plea hearing). Additionally, Eller offered no medical evidence
that a 30-mg delayed dose of Cymbalta can impair cognitive functioning so as to
incapacitate him. See United States v. Murphy, 572 F.3d 563, 569–70 (8th Cir. 2009).
And Eller did not complain of any side effects until weeks after his plea hearing.
Consequently, the record contains no evidence that Eller’s medication had an effect
on his competency.
Finally, the timing of Eller’s attempted withdrawal is problematic; he did not
attempt to withdraw his plea until after the PSR was prepared. Discomfort with the
PSR recommendations provide a credible, competing rationale for Eller’s late change
of plea. See Taylor, 515 F.3d at 851; Prior, 107 F.3d at 658.
-6-
In short, Eller did not meet his burden of establishing a fair and just grounds
for withdrawal. The district court did not abuse its discretion.
III. Conclusion
For the foregoing reasons, we affirm.
______________________________
-7-